1 / 10

Aarkstore - Pandemic Influenza-Pipeline Insights, 2014

Pandemic Influenza-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Pandemic Influenza. Browse Full Report @ http://bit.ly/1CLpoys

addyparker2350
Download Presentation

Aarkstore - Pandemic Influenza-Pipeline Insights, 2014

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category : Healthcare Pandemic Influenza-Pipeline Insights, 2014 Browse Complete Report - http://www.aarkstore.com/healthcare/77313/-pandemic-influenza-pipeline-insights-2014 f

  2. f Executive Summary Pandemic Influenza-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Pandemic Influenza. This report provides information on the therapeutic development based on the Pandemic Influenza dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

  3. f Data Sources The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

  4. f Scope The report provides a snapshot of the global therapeutic landscape of Pandemic InfluenzaThe report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical informationCoverage of the Pandemic Influenza pipeline on the basis of target, MOA, route of administration, technology involved and molecule typeThe report reviews key players involved in the therapeutics development for Pandemic Influenza and also provide company profilingThe report also gives the information of dormant and discontinued pipeline projects Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

  5. Table of Content Pandemic Influenza OverviewPandemic Influenza Pipeline TherapeuticsPandemic Influenza Therapeutics under Development by Companies Pandemic Influenza Late Stage Products (Filed and Phase III)Comparative Analysis Pandemic Influenza Mid Clinical Stage Products (Phase II)Comparative Analysis Pandemic Influenza Early Clinical Stage Products (Phase I and IND Filed)Comparative Analysis Pandemic Influenza Discovery and Pre-Clinical Stage Products Comparative Analysis Drug Candidate ProfilesPandemic Influenza Therapeutics Assessment Assessment by Monotherapy Products Assessment by Combination Products Assessment by Route of Administration Assessment by Molecule Type Pandemic Influenza Discontinued Products Pandemic Influenza Dormant Products Companies Involved in Therapeutics Development for Pandemic Influenza Appendix Methodology 

  6. f List Of Tables Number of Products under Development for Pandemic Influenza, 2014Number of Products under Development by Companies Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014Comparative Analysis Mid Clinical Stage Products (Phase II), 2014Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014Drug Candidates ProfilesPandemic Influenza Assessment by Monotherapy Products Pandemic Influenza Assessment by Combination Products Pandemic Influenza Assessment by Route of Administration Pandemic Influenza Assessment by Stage and Route of Administration Pandemic Influenza Assessment by Molecule Type Pandemic Influenza Assessment by Stage and Molecule Type Pandemic Influenza Therapeutics Discontinued Products Pandemic Influenza Therapeutics Dormant ProductsProducts under Development by Companies, 2014

  7. List Of Tables Number of Products under Development for Pandemic Influenza, 2014Late Clinical Stage Products (Filed and Phase III), 2014Mid Clinical Stage Products (Phase II), 2014Early Clinical Stage Products (Phase I and IND Filed), 2014Discovery and Pre-Clinical Stage Products, 2014Pandemic Influenza Assessment by Monotherapy Products Pandemic Influenza Assessment by Combination Products Pandemic Influenza Assessment by Route of Administration Pandemic Influenza Assessment by Stage and Route of Administration Pandemic Influenza Assessment by Molecule Type Pandemic Influenza Assessment by Stage and Molecule Type

  8. f Related Reports Sjogrens Syndrome Global Clinical Trials Review, H2, 2014 Human Papillomavirus Infections Global Clinical Trials Review, H2, 2014 Hospital Acquired Pneumonia (HAP) Global Clinical Trials Review, H2, 2014 Influenza A and B Infections Global Clinical Trials Review, H2, 2014 Empty Capsules Market by Product (Hard gelatin, Non-gelatin capsules), Raw Material (Pig meat, Bovine, HPMC), Therapeutic Application (Antibiotics, Vitamins) & by End User (Pharmaceutical, Health Supplements) - Global Forecast to 2019 Acute Asthma Global Clinical Trials Review, H2, 2014 Global Cystic Fibrosis Market 2015-2019 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa United States Anesthesia Drugs Market & Forecast Global Type 2 Diabetes Therapeutics Market 2015-2019

  9. f Pandemic Influenza-Pipeline Insights, 2014 Published: Dec. 2014 | 60 Pages Pandemic Influenza-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Pandemic Influenza.Price

  10. f Contact Us You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953

More Related